MA SONGJIANG (President) sold 0.1% of their position (2.18K shares) of GYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $23.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 5/27/2025ACC: 0001140361-25-020474
DirectorOfficer· President
Since Oct 2023
-2.18K
Net shares
Net seller
$23.8K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.18K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−2K
Price / share
$10.97
Trade value
$21.94K
% of position
0.1%
5/22/2025
2.81M→2.81M
Common Stock
Indirect
Shares
−182.00
Price / share
$10.24
Trade value
$1.86K
% of position
0.0%
5/23/2025
2.81M→2.81M
Total
Net shares
−2.18K
Net value
-$23.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/22/2025 | S · Sale | −2K | $10.97 | $21.94K | 0.1% | 2.81M | 2.81M |
| Common Stock Indirect | 5/23/2025 | S · Sale | −182.00 | $10.24 | $1.86K | 0.0% | 2.81M | 2.81M |
| Total | −2.18K | -$23.80K | ||||||
Derivative Transactions0
No derivative transactions reported